全文获取类型
收费全文 | 7708篇 |
免费 | 464篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 111篇 |
妇产科学 | 128篇 |
基础医学 | 1124篇 |
口腔科学 | 286篇 |
临床医学 | 708篇 |
内科学 | 1689篇 |
皮肤病学 | 379篇 |
神经病学 | 940篇 |
特种医学 | 406篇 |
外科学 | 985篇 |
综合类 | 34篇 |
预防医学 | 307篇 |
眼科学 | 125篇 |
药学 | 462篇 |
中国医学 | 2篇 |
肿瘤学 | 483篇 |
出版年
2024年 | 3篇 |
2023年 | 41篇 |
2022年 | 80篇 |
2021年 | 181篇 |
2020年 | 141篇 |
2019年 | 140篇 |
2018年 | 149篇 |
2017年 | 132篇 |
2016年 | 204篇 |
2015年 | 223篇 |
2014年 | 280篇 |
2013年 | 354篇 |
2012年 | 629篇 |
2011年 | 597篇 |
2010年 | 378篇 |
2009年 | 347篇 |
2008年 | 606篇 |
2007年 | 598篇 |
2006年 | 574篇 |
2005年 | 560篇 |
2004年 | 475篇 |
2003年 | 422篇 |
2002年 | 432篇 |
2001年 | 83篇 |
2000年 | 45篇 |
1999年 | 85篇 |
1998年 | 95篇 |
1997年 | 74篇 |
1996年 | 42篇 |
1995年 | 41篇 |
1994年 | 27篇 |
1993年 | 30篇 |
1992年 | 15篇 |
1991年 | 21篇 |
1990年 | 14篇 |
1989年 | 8篇 |
1988年 | 12篇 |
1987年 | 6篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1976年 | 4篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1969年 | 4篇 |
排序方式: 共有8215条查询结果,搜索用时 0 毫秒
101.
Skin thickness on the extremities of patients with diabetes mellitus has been described controversially. Using high resolution ultrasonography, we were able to show a significant increase in skin thickness at the forearm (P<0.05), thigh (P<0.001) and lower limb (P<0.05) of diabetic patients, most prominent at the thigh. No difference in skin thickness was found at the dorsum of the foot. In addition, skin thickness was not related to the duration of diabetes, age or HbA1. A close association was found between diabetic neuropathy and increasing skin thickness. Diabetic patients with neurological disorders had a significant increase in skin thickness versus diabetic patients without neuropathy. The present findings suggest that diabetic neuropathy and abnormalities of connective tissue have a common etiological link in their development or that both are time-dependent processes. Whether changes in capillary blood flow, increase of nonenzymatic glycosylation, polyol accumulation or other metabolic disorders are responsible for these findings remains still to be established. 相似文献
102.
103.
104.
105.
106.
107.
Linda Pilgaard Joachim Høg Mortensen Michael Henriksen Pia Olesen Preben Sørensen Rene Laursen Mogens Vyberg Ralf Agger Vladimir Zachar Torben Moos Meg Duroux 《Brain pathology (Zurich, Switzerland)》2014,24(4):360-370
Human glioblastoma multiforme (GBM) is an aggressive cancer with a very poor prognosis. Cripto‐1 (CR‐1) has a key regulatory role in embryogenesis, while in adult tissue re‐expression of CR‐1 has been correlated to malignant progression in solid cancers of non‐neuronal origin. As CR‐1 expression has yet to be described in cerebral cancer and CR‐1 is regulated by signaling pathways dysregulated in GBM, we aimed to investigate CR‐1 in the context of expression in GBM. The study was performed using enzyme‐linked immunosorbent assay (ELISA), Western blotting, polymerase chain reaction (PCR) and immunohistochemistry to analyze the blood and tissue from 28 GBM and 4 low‐grade glioma patients. Within the patient cohort, we found high CR‐1 protein levels in blood plasma to significantly correlate with a shorter overall survival. We identified CR‐1 in different areas of GBM tissue, including perivascular tumor cells, and in endothelial cells. Collectively, our data suggest that CR‐1 could be a prognostic biomarker for GBM with the potential of being a therapeutic target. 相似文献
108.
Désirée Rutschow Ralf Bauer Caroline G?hringer Raffi Bekeredjian Stefanie Schinkel Volker Straub Michael Koenen Dieter Weichenhan Hugo A Katus Oliver J Müller 《European journal of human genetics : EJHG》2014,22(1):119-125
So far, the role of mutations in the δ-sarcogylcan (Sgcd) gene in causing autosomal dominant dilated cardiomyopathy (DCM) remains inconclusive. A p.S151A missense mutation in exon 6 of the Sgcd gene was reported to cause severe isolated autosomal dominant DCM without affecting skeletal muscle. This is controversial to our previous findings in a large consanguineous family where this p.S151A mutation showed no relevance for cardiac disease. In this study, the potential of the p.S151A mutation to cause DCM was investigated by using two different approaches: (1) engineering and characterization of heterozygous knock-in (S151A-) mice carrying the p.S151A mutation and (2) evaluation of the potential of adeno-associated virus (AAV) 9-based cardiac-specific transfer of p.S151A-mutated Sgcd cDNA to rescue the cardiac phenotype in Sgcd-deficient (Sgcd-null) mice as it has been demonstrated for intact, wild-type Sgcd cDNA. Heterozygous S151A knock-in mice developed a rather mild phenotype of cardiomyopathy. Increased heart to body weight suggests cardiac enlargement in 1-year-old S151A knock-in mice. However, at this age cardiac function, assessed by echocardiography, is maintained and histopathology completely absent. Myocardial expression of p.S151A cDNA, similar to intact Sgcd cDNA, restores cardiac function, although not being able to prevent myocardial histopathology in Sgcd-null mice completely. Our results suggest that the p.S151A mutation causes a mild, subclinical phenotype of cardiomyopathy, which is prone to be overseen in patients carrying such sequence variants. Furthermore, this study shows the suitability of an AAV-mediated cardiac gene transfer approach to analyze whether a sequence variant is a disease-causing mutation. 相似文献
109.
Rey JW Hansen T Dümcke S Tresch A Kramer K Galle PR Goetz M Schuchmann M Kiesslich R Hoffman A 《World journal of gastrointestinal endoscopy》2014,6(4):137-143
AIM: To evaluate the diagnostic yield(inflammatory activity) and efficiency(size of the biopsy specimen) of SpyGlassTM-guided biopsy vs standard brush cytology in patients with and without primary sclerosing cholangitis(PSC).METHODS: At the University Medical Center Mainz, Germany, 35 consecutive patients with unclear biliarylesions(16 patients) or long-standing PSC(19 patients) were screened for the study. All patients underwent a physical examination, lab analyses, and abdominal ultrasound. Thirty-one patients with non-PSC strictures or with PSC were scheduled to undergo endoscopic retrograde cholangiography(ERC) and subsequent per-oral cholangioscopy(POC). Standard ERC was initially performed, and any lesions or strictures were localized. POC was performed later during the same session. The Boston Scientific SpyGlass SystemTM(Natick, MA, United States) was used for choledochoscopy. The biliary tree was visualized, and suspected lesions or strictures were biopsied, followed by brush cytology of the same area. The study endpoints(for both techniques) were the degree of inflammation, tissue specimen size, and the patient populations(PSC vs non-PSC). Inflammatory changes were divided into three categories: none, low activity, and high activity. The specimen quantity was rated as low, moderate, or sufficient.RESULTS: SpyGlassTM imaging and brush cytology with material retrieval were performed in 29 of 31(93.5%) patients(23 of the 29 patients were male). The median patient age was 45 years(min, 20 years; max, 76 years). Nineteen patients had known PSC, and 10 showed non-PSC strictures. No procedure-related complications were encountered. However, for both methods, tissues could only be retrieved from 29 pa-tients. In cases of inflammation of the biliary tract, the diagnostic yield of the SpyGlassTM-directed biopsies was greater than that using brush cytology. More tissue material was obtained for the biopsy method than for the brush cytology method(P = 0.021). The biopsies showed significantly more inflammatory characteristics and greater inflammatory activity compared to the cy-tological investigation(P = 0.014). The greater quantity of tissue samples proved useful for both PSC and non-PSC patients.CONCLUSION: SpyGlassTM imaging can be recom-mended for proper inflammatory diagnosis in PSC pa-tients. However, its value in diagnosing dysplasia wasnot addressed in this study and requires further investi-gation. 相似文献
110.